Copyright
©The Author(s) 2020.
World J Gastroenterol. Jul 21, 2020; 26(27): 3938-3951
Published online Jul 21, 2020. doi: 10.3748/wjg.v26.i27.3938
Published online Jul 21, 2020. doi: 10.3748/wjg.v26.i27.3938
Table 2 Pre-contrast and contrast-enhanced ultrasound features of 228 lesions, n (%)
| Imaging characteristic | Pathology | P value | |
| ICC (n = 99) | LR-M HCC (n = 129) | ||
| Gray scale echogenicity | |||
| Hyperechoic | 4 (4) | 39 (30.0) | < 0.001 |
| Hypoechoic | 93 (93.9) | 82 (63.1) | < 0.001 |
| Mixed | 2 (2) | 8 (6.9) | > 0.05 |
| APHE | |||
| Homogeneous | 15 (15.2) | 48 (37.2) | < 0.001 |
| Heterogeneous | 34 (34.3) | 60 (46.5) | > 0.05 |
| Rim | 50 (50.5) | 21 (16.3) | < 0.001 |
| Early washout (onset < 60 s) | 93 (93.4) | 124 (96.1) | > 0.05 |
| Marked washout within 120 s | 23 (23.2) | 10 (7.8) | = 0.002 |
- Citation: Huang JY, Li JW, Ling WW, Li T, Luo Y, Liu JB, Lu Q. Can contrast enhanced ultrasound differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma? World J Gastroenterol 2020; 26(27): 3938-3951
- URL: https://www.wjgnet.com/1007-9327/full/v26/i27/3938.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i27.3938